Equity Research, Broker Reports, and media content on ABLYNX NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ABLYNX NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ABLYNX NV. We currently have 0 research reports from 0 professional analysts.

Open
11.1
Volume
0.1m
Range
11.1/11.3
Market Cap
685,914,532m
52 Week
8.20/14.7
Date Source Announcement
22May17 06:00 GNW NOVEL NANOBODY TO START CLINICAL DEVELOPMENT IN OSTEOARTHRITIS - ABLYNX TO RECEIVE €15 MILLION MILESTONE PAYMENT
16May17 06:00 GNW ABLYNX TO PRESENT AT UPCOMING USA INVESTOR CONFERENCES
11May17 06:02 GNW ABLYNX REPORTS FINANCIAL RESULTS FOR THE FIRST THREE MONTHS OF 2017 AND A YEAR-TO-DATE BUSINESS UPDATE
02May17 06:00 GNW ABLYNX COMPLETES PATIENT RECRUITMENT IN ITS PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF aTTP
21Apr17 06:02 GNW ABLYNX ANNOUNCES WARRANT EXERCISE
06Mar17 06:00 GNW ABLYNX'S PARTNER, MERCK KGaA, HAS PRESENTED NEW DATA FROM A PHASE Ib PSORIASIS STUDY OF THE BI-SPECIFIC ANTI-IL-17A/F NANOBODY AT THE ANNUAL AAD CONFERENCE
23Feb17 06:00 GNW ABLYNX ANNOUNCES 2016 FULL YEAR RESULTS
  • Frequency of research reports

     

  • Research reports on

    ABLYNX NV

  • Providers covering

    ABLYNX NV